The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

Ayalew Tefferi; Terra L. Lasho; Alexander Tischer; Emnet A. Wassie; Christy M. Finke; Alem A. Belachew; Rhett P. Ketterling; Curtis A. Hanson; Animesh D. Pardanani

doi:10.1182/blood-2014-07-588426

The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

Ayalew Tefferi, Terra L. Lasho, Alexander Tischer, Emnet A. Wassie, Christy M. Finke, Alem A. Belachew, Rhett P. Ketterling, Curtis A. Hanson, Animesh D. Pardanani

Research output: Contribution to journal › Letter › peer-review

105 Scopus citations

Original language	English (US)
Pages (from-to)	2465-2466
Number of pages	2
Journal	Blood
Volume	124
Issue number	15
DOIs	https://doi.org/10.1182/blood-2014-07-588426
State	Published - Oct 9 2014

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2014-07-588426

Cite this

@article{6ee5cacd8cc84d7592223b4fa69f6119,

title = "The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants",

author = "Ayalew Tefferi and Lasho, {Terra L.} and Alexander Tischer and Wassie, {Emnet A.} and Finke, {Christy M.} and Belachew, {Alem A.} and Ketterling, {Rhett P.} and Hanson, {Curtis A.} and Pardanani, {Animesh D.}",

year = "2014",

month = oct,

day = "9",

doi = "10.1182/blood-2014-07-588426",

language = "English (US)",

volume = "124",

pages = "2465--2466",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "15",

}

TY - JOUR

T1 - The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

AU - Tefferi, Ayalew

AU - Lasho, Terra L.

AU - Tischer, Alexander

AU - Wassie, Emnet A.

AU - Finke, Christy M.

AU - Belachew, Alem A.

AU - Ketterling, Rhett P.

AU - Hanson, Curtis A.

AU - Pardanani, Animesh D.

PY - 2014/10/9

Y1 - 2014/10/9

UR - http://www.scopus.com/inward/record.url?scp=84908065771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908065771&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-07-588426

DO - 10.1182/blood-2014-07-588426

M3 - Letter

C2 - 25301336

AN - SCOPUS:84908065771

SN - 0006-4971

VL - 124

SP - 2465

EP - 2466

JO - Blood

JF - Blood

IS - 15

ER -

The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this